RPRD1B antibody

Synonyms:Regulation of nuclear pre-mRNA domain-containing protein 1B|Cell cycle-related and expression-elevated protein in tumor|RPRD1B|C20orf77|CREPT antibody
Catalogue No.:FNab07456Reactivity:Human
Host:RabbitTested Application:ELISA, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
RPRD1B antibody
Catalogue No.
FNab07456
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
regulation of nuclear pre-mRNA domain containing 1B
Alternative Names
Regulation of nuclear pre-mRNA domain-containing protein 1B|Cell cycle-related and expression-elevated protein in tumor|RPRD1B|C20orf77|CREPT antibody
UniProt ID
Q9NQG5
Observed MW
37 kDa
Application
Tested Applications
ELISA, WB
Recommended dilution
WB: 1:500-1:2000
Validated Images
HeLa cells were subjected to SDS PAGE followed by western blot with FNab07456( RPRD1B Antibody) at dilution of 1:1000
Background
Interacts with phosphorylated C-terminal heptapeptide repeat domain(CTD) of the largest RNA polymerase II subunit POLR2A, and participates in dephosphorylation of the CTD. Transcriptional regulator which enhances expression of CCND1. Promotes binding of RNA polymerase II to the CCDN1 promoter and to the termination region before the poly-A site but decreases its binding after the poly-A site. Prevents RNA polymerase II from reading through the 3' end termination site and may allow it to be recruited back to the promoter through promotion of the formation of a chromatin loop. Also enhances the transcription of a number of other cell cycle-related genes including CDK2, CDK4, CDK6 and cyclin-E but not CDKN1A, CDKN1B or cyclin-A. Promotes cell proliferation.